Alzheimer’s Disease Diagnostic Market Report 2026
Download Free Sample Buy Now
Alzheimer’s Disease Diagnostic Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Alzheimer’s Disease Diagnostic Market Report 2026

Global Outlook – By Type (Triage, Diagnosis, Screening), By Diagnostic Technique (Biomarkers, Imaging Techniques, Genetic Testing, Cognitive Assessment Tests), By End User (Clinics, Hospitals, Diagnostic Centers, Pharmaceutical Companies, Academic Research Center) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Alzheimer’s Disease Diagnostic Market Overview

• Alzheimer’s Disease Diagnostic market size has reached to $7.26 billion in 2025

• Expected to grow to $11.89 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%

• Growth Driver: Impact Of Chronic Disease Growth On Alzheimer’s Disease Diagnostic Industry

• Market Trend: Advancements In Technology In Alzheimer’s Diagnostic With Accurate Test Results

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Alzheimer’s Disease Diagnostic Market?

Alzheimer’s disease diagnostics encompass methods and tools used to detect and confirm the presence of Alzheimer’s disease, a progressive neurodegenerative disorder. These diagnostics include cognitive assessments, imaging techniques such as magnetic resonance imaging (MRI) and positron emission tomography (PET) scans, and biomarker tests analyzing cerebrospinal fluid (CSF) or blood for amyloid-beta and tau proteins.

The main types of alzheimer’s disease diagnostics are triage, diagnosis, and screening. Triage is a systematic approach for prioritizing patients depending on the urgency and severity of their cognitive symptoms. The diagnostic techniques include biomarkers, imaging techniques, genetic testing, and cognitive assessment tests, and they are used by various end users such as clinics, hospitals, diagnostic centers, pharmaceutical companies, and academic research centers.

Alzheimer’s Disease Diagnostic Market Global Report 2026 Market Report bar graph

What Is The Alzheimer’s Disease Diagnostic Market Size and Share 2026?

The alzheimer’s disease diagnostic market size has grown rapidly in recent years. It will grow from $7.26 billion in 2025 to $8.03 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to rising prevalence of alzheimer’s disease, increased awareness of neurodegenerative disorders, adoption of mri and pet imaging, growth of diagnostic centers and hospitals, investment in cognitive assessment research.

What Is The Alzheimer’s Disease Diagnostic Market Growth Forecast?

The alzheimer’s disease diagnostic market size is expected to see rapid growth in the next few years. It will grow to $11.89 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to development of novel biomarkers and imaging tracers, integration of ai for early diagnosis, rising government and private funding for alzheimer’s research, expansion of personalized medicine initiatives, growth in multi-center clinical trials. Major trends in the forecast period include increasing adoption of biomarker-based diagnostics, rising use of neuroimaging techniques for early detection, growth in cognitive assessment testing, expansion of genetic testing for alzheimer’s risk assessment, integration of multi-modal diagnostic approaches.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Alzheimer’s Disease Diagnostic Market Segmentation

1) By Type: Triage, Diagnosis, Screening

2) By Diagnostic Technique: Biomarkers, Imaging Techniques, Genetic Testing, Cognitive Assessment Tests

3) By End User: Clinics, Hospitals, Diagnostic Centers, Pharmaceutical Companies, Academic Research Center

Subsegments:

1) By Triage: Cognitive Testing, Imaging Techniques

2) By Diagnosis: Biomarker Testing, Neuroimaging

3) By Screening: Neuropsychological Testing, Genetic Testing

What Is The Driver Of The Alzheimer’s Disease Diagnostic Market?

The increase in chronic disease is expected to propel the growth of the Alzheimer’s disease diagnostic market going forward. Chronic diseases such as cardiovascular disease, diabetes, and hypertension are strongly associated with an increased risk of Alzheimer’s and other dementias, which drives demand for early and accurate diagnostic solutions. A major factor behind the increase in chronic diseases is the widespread rise in sedentary lifestyles, as extensive epidemiological research consistently shows significantly higher rates of conditions such as diabetes and cardiovascular disease among physically inactive populations. Alzheimer’s diagnostics support healthcare systems by enabling early detection, facilitating timely interventions, and guiding patient management to slow disease progression. For instance, in November 2023, according to Heritage Health Services, a US-based nonprofit organization focused on healthcare research, 6.7 million Americans aged 65 or older were living with Alzheimer’s dementia, with prevalence increasing by age: 5.0% for 65–74 years, 13.1% for 75–84 years, and 33.3% for 85+ years. By 2050, this number is projected to rise to nearly 13 million. Therefore, the increase in chronic disease is driving the growth of the Alzheimer’s disease diagnostic industry.

Key Players In The Global Alzheimer’s Disease Diagnostic Market

Major companies operating in the alzheimer’s disease diagnostic market are Hoffmann-La Roche, Eli Lilly and Company, Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Lantheus, Quanterix, C2N Diagnostics, Sysmex, Royal Philips, Bruker Corporation, Revvity, Alamar Biosciences, ADx Neurosciences, Randox Laboratories, DiaSorin, Shenzhen Mindray Bio-Medical Electronics, Nipro Corporation, Canon Inc, Hitachi Ltd, Eisai Co Ltd

Global Alzheimer’s Disease Diagnostic Market Trends and Insights

Major companies operating in the alzheimer’s disease diagnostic market are focusing on advancements of blood-based biomarker test which is expected to simplify the diagnostic process for Alzheimer's disease, reducing reliance on more invasive procedures and improving access to timely treatment for patients. For instance, in October 2023, Quanterix, a US-based biotechnology research company, launched LucentAD p-Tau 217 test, a biomarker for Alzheimer's pathology with clinical sensitivity and specificity in blood. Traditional approaches for cerebrospinal fluid (CSF) biomarkers include positron emission tomography (PET) or lumbar puncture, both of which are costly, invasive, and not widely available. Additionally, it combines Quanterix's ultra-sensitive SimoaÒ technology with J&J Innovative Medicine's well tested p-Tau 217 antibodies for excellent accuracy and a simpler process.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Alzheimer’s Disease Diagnostic Market?

In July 2024, Lantheus, a US-based radiopharmaceutical company, acquired Meilleur Technologies for an undisclosed amount. Through this acquisition, Lantherus aims in expanding its holdings of PET imaging agents for Alzheimer’s disease. Meilleur Technologies is a US biopharma company that has collaborated with research institutions to develop imaging biomarkers for Alzheimer's disease.

Regional Outlook

North America was the largest region in the alzheimer's disease diagnostic market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the alzheimer’s disease diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the alzheimer’s disease diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Alzheimer’s Disease Diagnostic Market?

The alzheimer's disease diagnostic market consists of revenues earned by entities by providing services such as cognitive assessment tests, genetic tests, biomarker tests, and cerebrospinal fluid analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The alzheimer's disease diagnostic market also includes sales of genetic testing kits, cognitive assessment tools, imaging equipment, biomarker kits, and wearable devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Alzheimer’s Disease Diagnostic Market Report 2026?

The alzheimer’s disease diagnostic market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the alzheimer’s disease diagnostic industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Alzheimer’s Disease Diagnostic Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $8.03 billion
Revenue Forecast In 2035 $11.89 billion
Growth Rate CAGR of 10.6% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Diagnostic Technique, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Hoffmann-La Roche, Eli Lilly and Company, Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Lantheus, Quanterix, C2N Diagnostics, Sysmex, Royal Philips, Bruker Corporation, Revvity, Alamar Biosciences, ADx Neurosciences, Randox Laboratories, DiaSorin, Shenzhen Mindray Bio-Medical Electronics, Nipro Corporation, Canon Inc, Hitachi Ltd, Eisai Co Ltd
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Alzheimer’s Disease Diagnostic Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Alzheimer’s Disease Diagnostic Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Alzheimer’s Disease Diagnostic Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Alzheimer’s Disease Diagnostic Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Biomarker-Based Diagnostics

4.2.2 Rising Use Of Neuroimaging Techniques For Early Detection

4.2.3 Growth In Cognitive Assessment Testing

4.2.4 Expansion Of Genetic Testing For Alzheimer’S Risk Assessment

4.2.5 Integration Of Multi-Modal Diagnostic Approaches

5. Alzheimer’s Disease Diagnostic Market Analysis Of End Use Industries

5.1 Clinics

5.2 Hospitals

5.3 Diagnostic Centers

5.4 Pharmaceutical Companies

5.5 Academic Research Centers

6. Alzheimer’s Disease Diagnostic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Alzheimer’s Disease Diagnostic Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Alzheimer’s Disease Diagnostic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Alzheimer’s Disease Diagnostic Market Size, Comparisons And Growth Rate Analysis

7.3. Global Alzheimer’s Disease Diagnostic Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Alzheimer’s Disease Diagnostic Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Alzheimer’s Disease Diagnostic Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Alzheimer’s Disease Diagnostic Market Segmentation

9.1. Global Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Triage, Diagnosis, Screening

9.2. Global Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Biomarkers, Imaging Techniques, Genetic Testing, Cognitive Assessment Tests

9.3. Global Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Clinics, Hospitals, Diagnostic Centers, Pharmaceutical Companies, Academic Research Center

9.4. Global Alzheimer’s Disease Diagnostic Market, Sub-Segmentation Of Triage, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cognitive Testing, Imaging Techniques

9.5. Global Alzheimer’s Disease Diagnostic Market, Sub-Segmentation Of Diagnosis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Biomarker Testing, Neuroimaging

9.6. Global Alzheimer’s Disease Diagnostic Market, Sub-Segmentation Of Screening, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Neuropsychological Testing, Genetic Testing

10. Alzheimer’s Disease Diagnostic Market Regional And Country Analysis

10.1. Global Alzheimer’s Disease Diagnostic Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Alzheimer’s Disease Diagnostic Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Alzheimer’s Disease Diagnostic Market

11.1. Asia-Pacific Alzheimer’s Disease Diagnostic Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Segmentation By Diagnostic Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Alzheimer’s Disease Diagnostic Market

12.1. China Alzheimer’s Disease Diagnostic Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Segmentation By Diagnostic Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Alzheimer’s Disease Diagnostic Market

13.1. India Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Segmentation By Diagnostic Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Alzheimer’s Disease Diagnostic Market

14.1. Japan Alzheimer’s Disease Diagnostic Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Segmentation By Diagnostic Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Alzheimer’s Disease Diagnostic Market

15.1. Australia Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Segmentation By Diagnostic Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Alzheimer’s Disease Diagnostic Market

16.1. Indonesia Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Segmentation By Diagnostic Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Alzheimer’s Disease Diagnostic Market

17.1. South Korea Alzheimer’s Disease Diagnostic Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Segmentation By Diagnostic Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Alzheimer’s Disease Diagnostic Market

18.1. Taiwan Alzheimer’s Disease Diagnostic Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Segmentation By Diagnostic Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Alzheimer’s Disease Diagnostic Market

19.1. South East Asia Alzheimer’s Disease Diagnostic Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Segmentation By Diagnostic Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Alzheimer’s Disease Diagnostic Market

20.1. Western Europe Alzheimer’s Disease Diagnostic Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Segmentation By Diagnostic Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Alzheimer’s Disease Diagnostic Market

21.1. UK Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Segmentation By Diagnostic Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Alzheimer’s Disease Diagnostic Market

22.1. Germany Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Segmentation By Diagnostic Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Alzheimer’s Disease Diagnostic Market

23.1. France Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Segmentation By Diagnostic Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Alzheimer’s Disease Diagnostic Market

24.1. Italy Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Segmentation By Diagnostic Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Alzheimer’s Disease Diagnostic Market

25.1. Spain Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Segmentation By Diagnostic Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Alzheimer’s Disease Diagnostic Market

26.1. Eastern Europe Alzheimer’s Disease Diagnostic Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Segmentation By Diagnostic Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Alzheimer’s Disease Diagnostic Market

27.1. Russia Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Segmentation By Diagnostic Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Alzheimer’s Disease Diagnostic Market

28.1. North America Alzheimer’s Disease Diagnostic Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Segmentation By Diagnostic Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Alzheimer’s Disease Diagnostic Market

29.1. USA Alzheimer’s Disease Diagnostic Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Segmentation By Diagnostic Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Alzheimer’s Disease Diagnostic Market

30.1. Canada Alzheimer’s Disease Diagnostic Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Segmentation By Diagnostic Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Alzheimer’s Disease Diagnostic Market

31.1. South America Alzheimer’s Disease Diagnostic Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Segmentation By Diagnostic Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Alzheimer’s Disease Diagnostic Market

32.1. Brazil Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Segmentation By Diagnostic Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Alzheimer’s Disease Diagnostic Market

33.1. Middle East Alzheimer’s Disease Diagnostic Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Segmentation By Diagnostic Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Alzheimer’s Disease Diagnostic Market

34.1. Africa Alzheimer’s Disease Diagnostic Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Segmentation By Diagnostic Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Alzheimer’s Disease Diagnostic Market Regulatory and Investment Landscape

36. Alzheimer’s Disease Diagnostic Market Competitive Landscape And Company Profiles

36.1. Alzheimer’s Disease Diagnostic Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Alzheimer’s Disease Diagnostic Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Alzheimer’s Disease Diagnostic Market Company Profiles

36.3.1. Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Lantheus Overview, Products and Services, Strategy and Financial Analysis

37. Alzheimer’s Disease Diagnostic Market Other Major And Innovative Companies

Quanterix, C2N Diagnostics, Sysmex, Royal Philips, Bruker Corporation, Revvity, Alamar Biosciences, ADx Neurosciences, Randox Laboratories, DiaSorin, Shenzhen Mindray Bio-Medical Electronics, Nipro Corporation, Canon Inc, Hitachi Ltd, Eisai Co Ltd

38. Global Alzheimer’s Disease Diagnostic Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Alzheimer’s Disease Diagnostic Market

40. Alzheimer’s Disease Diagnostic Market High Potential Countries, Segments and Strategies

40.1 Alzheimer’s Disease Diagnostic Market In 2030 - Countries Offering Most New Opportunities

40.2 Alzheimer’s Disease Diagnostic Market In 2030 - Segments Offering Most New Opportunities

40.3 Alzheimer’s Disease Diagnostic Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Alzheimer’s Disease Diagnostic Market, Overview Of Key Products - Product Examples
  • Table 2: Global Alzheimer’s Disease Diagnostic Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Alzheimer’s Disease Diagnostic Market, Supply Chain Analysis
  • Table 4: Global Alzheimer’s Disease Diagnostic Market, Major Raw Material Providers
  • Table 5: Global Alzheimer’s Disease Diagnostic Market, Major Resource Providers
  • Table 6: Global Alzheimer’s Disease Diagnostic Market, Major Manufacturers (Suppliers)
  • Table 7: Global Alzheimer’s Disease Diagnostic Market, Major Distributors And Channel Partners
  • Table 8: Global Alzheimer’s Disease Diagnostic Market, Key Technologies & Future Trends
  • Table 9: Global Alzheimer’s Disease Diagnostic Market, Major Trends
  • Table 10: Global Alzheimer’s Disease Diagnostic Market, Major End Users
  • Table 11: Global Alzheimer’s Disease Diagnostic Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Alzheimer’s Disease Diagnostic Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Alzheimer’s Disease Diagnostic Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Alzheimer’s Disease Diagnostic Market - TAM, US$ Billion, 2025
  • Table 15: Global Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Alzheimer’s Disease Diagnostic Market, Sub-Segmentation Of Triage, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Alzheimer’s Disease Diagnostic Market, Sub-Segmentation Of Diagnosis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Alzheimer’s Disease Diagnostic Market, Sub-Segmentation Of Screening, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Alzheimer’s Disease Diagnostic Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Alzheimer’s Disease Diagnostic Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Global Alzheimer’s Disease Diagnostic Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 96: Global Alzheimer’s Disease Diagnostic Market - Company Scoring Matrix
  • Table 97: Hoffmann-La Roche Financial Performance
  • Table 98: Eli Lilly and Company Financial Performance
  • Table 99: Quest Diagnostics Incorporated Financial Performance
  • Table 100: Laboratory Corporation of America Holdings Financial Performance
  • Table 101: Lantheus Financial Performance
  • Table 102: Global Alzheimer’s Disease Diagnostic Market, Competitive Benchmarking (In USD Billions)
  • Table 103: Global Alzheimer’s Disease Diagnostic Market, Competitive Dashboard
  • Table 104: Global Alzheimer’s Disease Diagnostic Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 105: Global, Alzheimer’s Disease Diagnostic Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 106: Global, Alzheimer’s Disease Diagnostic Market Size Gain ($ Billion), Segmentation By Diagnostic Technique, 2025 – 2030
  • Table 107: Global, Alzheimer’s Disease Diagnostic Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

    Figure 1: Global Alzheimer’s Disease Diagnostic Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Alzheimer’s Disease Diagnostic Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Alzheimer’s Disease Diagnostic Market, Supply Chain Analysis
  • Figure 4: Global Alzheimer’s Disease Diagnostic Market, Major Raw Material Providers
  • Figure 5: Global Alzheimer’s Disease Diagnostic Market, Major Resource Providers
  • Figure 6: Global Alzheimer’s Disease Diagnostic Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Alzheimer’s Disease Diagnostic Market, Major Distributors And Channel Partners
  • Figure 8: Global Alzheimer’s Disease Diagnostic Market, Key Technologies & Future Trends
  • Figure 9: Global Alzheimer’s Disease Diagnostic Market, Major Trends
  • Figure 10: Global Alzheimer’s Disease Diagnostic Market, Major End Users
  • Figure 11: Global Alzheimer’s Disease Diagnostic Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Alzheimer’s Disease Diagnostic Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Alzheimer’s Disease Diagnostic Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Alzheimer’s Disease Diagnostic Market - TAM, US$ Billion, 2025
  • Figure 15: Global Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Alzheimer’s Disease Diagnostic Market, Sub-Segmentation Of Triage, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Alzheimer’s Disease Diagnostic Market, Sub-Segmentation Of Diagnosis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Alzheimer’s Disease Diagnostic Market, Sub-Segmentation Of Screening, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Alzheimer’s Disease Diagnostic Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Alzheimer’s Disease Diagnostic Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Alzheimer’s Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Alzheimer’s Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Alzheimer’s Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Global Alzheimer’s Disease Diagnostic Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 96: Global Alzheimer’s Disease Diagnostic Market - Company Scoring Matrix
  • Figure 97: Hoffmann-La Roche Financial Performance
  • Figure 98: Eli Lilly and Company Financial Performance
  • Figure 99: Quest Diagnostics Incorporated Financial Performance
  • Figure 100: Laboratory Corporation of America Holdings Financial Performance
  • Figure 101: Lantheus Financial Performance
  • Figure 102: Global Alzheimer’s Disease Diagnostic Market, Competitive Benchmarking (In USD Billions)
  • Figure 103: Global Alzheimer’s Disease Diagnostic Market, Competitive Dashboard
  • Figure 104: Global Alzheimer’s Disease Diagnostic Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 105: Global, Alzheimer’s Disease Diagnostic Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 106: Global, Alzheimer’s Disease Diagnostic Market Size Gain ($ Billion), Segmentation By Diagnostic Technique, 2025 – 2030
  • Figure 107: Global, Alzheimer’s Disease Diagnostic Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Alzheimer's Drugs Market Report 2026 - Global Outlook – By Drugs (Donepezil, Rivastigmine, Galantamine, Memantine ), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy ), By Application (Early T...

Alzheimer's Drugs Market Report 2026 - Global Outlook – By Drugs (Donepezil, Rivastigmine, Galantamine, Memantine ), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy ), By Application (Early T...

Neurological Biomarkers Market Report 2026 - Global Outlook – By Product (Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Other Products), By Application (Alzheimer’s Disease, Parkins...

Autism Spectrum Disorder Diagnostics Market Report 2026 - Global Outlook – By Diagnostic Method (Behavioral And Developmental Screening Tools, Standardized Diagnostic Assessments, Genetic And Molecular Testing, Digital A...

Clinical Diagnostics Market Report 2026 - Global Outlook – By Test (Lab Test, Imaging Test, Other Tests), By Product (Instruments, Reagents, Other Products ), By End User (Hospital Laboratory, Diagnostic Laboratory, Poin...

Lewy Body Dementia Treatment Market Report 2026 - Global Outlook – By Drug Type (Antidepressants, Carbidopa-Levodopa, Cholinesterase Inhibitors), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online P...

Neuroscience Antibodies & Assays Market Report 2026 - Global Outlook – By Product (Consumables, Instruments), By Technology (Molecular Diagnostics, Immunoassays Or Immunochemistry, Other Technologies), By Application (In...

Paper Diagnostics Market Report 2026 - Global Outlook – By Product (Dipsticks, Lateral Flow Assays (Paper-Based Microfluidics), By Application (Environmental Monitoring, Clinical Diagnostics, Food Quality Testing), By En...

Frequently Asked Questions

The Alzheimer’s Disease Diagnostic market was valued at $7.26 billion in 2025, increased to $8.03 billion in 2026, and is projected to reach $11.89 billion by 2030.

The global Alzheimer’s Disease Diagnostic market is expected to grow at a CAGR of 10.3% from 2026 to 2035 to reach $11.89 billion by 2035.

Some Key Players in the Alzheimer’s Disease Diagnostic market Include, Hoffmann-La Roche, Eli Lilly and Company, Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Lantheus, Quanterix, C2N Diagnostics, Sysmex, Royal Philips, Bruker Corporation, Revvity, Alamar Biosciences, ADx Neurosciences, Randox Laboratories, DiaSorin, Shenzhen Mindray Bio-Medical Electronics, Nipro Corporation, Canon Inc, Hitachi Ltd, Eisai Co Ltd .

Major trend in this market includes: Advancements In Technology In Alzheimer’s Diagnostic With Accurate Test Results. For further insights on this market. request a sample here

North America was the largest region in the alzheimer's disease diagnostic market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the alzheimer’s disease diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us